Open main menu

Kogic.net β

Changes

Changjae Kim

625 bytes added, 08:56, 3 December 2018
no edit summary
<p><span style="font-size:16px"><strong>Education</strong></span></p>
<p><strong>2016-Present :&nbsp;</strong>Ph.D.<strong>&nbsp;</strong>KOrean Genomics Industrialization and Commercialization Center(KOGIC)</p>
<p><strong>2008-</strong><strong>2016:&nbsp; </strong>Ph.D.&nbsp;Department of Internal Medicine and Biomedical Research Center, Ulsan University Hospital, University of Ulsan College of&nbsp;Medicine, Ulsan, Korea&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p>&nbsp;</p>
<p><span style="font-size:16px"><strong>Career</strong></span></p>
<ulp> <listrong>20162004-2005. 08&nbsp;- 현재 07: &nbsp; &nbsp;&nbsp;&nbsp;: &nbsp;책임연구원, 게놈연구소(TGI), UNIST</listrong> <li>2008. 03Research Assistant in Department of Pathology at Catholic University,&nbsp;- 2016. 07&nbsp;: &nbsp;울산대학교병원 중점연구소</li>Medical College, Seoul, Korea</ulp>
<p><strong>2005. 07- 2006. 01: </strong>Research Assistant in&nbsp;NIH/NIAID(National Institute of Allergy and Infectious Diseases)</p> <p><strong>2006-2008 : &nbsp;&nbsp;</strong>Research Assistant in Department of Pathology at Catholic University,Medical College, Seoul, Korea</p>
<p><strong>연구분야2008- 2016</strong>:&nbsp;&nbsp; Ph.D. Biomedical Research Center, Ulsan University Hospital, College of&nbsp;Medicine, University of Ulsan,</p>
<ulp> <listrong>종양생물학2016-Present :&nbsp;</listrong> Ph.D.<listrong>분자생물학&nbsp;</listrong>KOrean Genomics Industrialization and Commercialization Center(KOGIC)</ulp>
<h3p>&nbsp;</h3p>
<h3><span style="font-size:16px"><strong>논문Publications</strong></span></h3>
<p>56. Kim JH, Jung SW, Byun SS, Shin JW, Park BR, Kim MH,&nbsp;<strong><u>Kim CJ</u></strong>, Park NH. Efficacy and safety of tenofovir in nucleos(t)ide-na&iuml;ve patients with genotype C chronic hepatitis B in real-life practice. Int J Clin Pharm. 2015 Dec;37(6):1228-34.</p>
470
edits